VistaGen Therapeutics
VTGN
VTGN
57 hedge funds and large institutions have $81.8M invested in VistaGen Therapeutics in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% more ownership
Funds ownership: 53.13% → 76.13% (+23%)
12% more funds holding
Funds holding: 51 → 57 (+6)
Holders
57
Holding in Top 10
–
Calls
$2.68M
Puts
$574K
Top Buyers
| 1 | +$14.7M | |
| 2 | +$10.9M | |
| 3 | +$1.95M | |
| 4 |
Renaissance Technologies
New York
|
+$1.35M |
| 5 |
Jane Street
New York
|
+$737K |
Top Sellers
| 1 | -$1.69M | |
| 2 | -$1.09M | |
| 3 | -$896K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$260K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$255K |
